ABLA
LLY icon

Alan B. Lancz & Associates’s Eli Lilly LLY Stock Holding History

Alan B. Lancz & Associates’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.3M Sell
1,415
-155
-10% -$157K 1.26% 17
2025
Q4 		$1.69M Hold
1,570
– – 1.48% 13
2025
Q3 		$1.2M Buy
1,570
+40
+3% +$29.8K 1.08% 19
2025
Q2 		$1.19M Hold
1,530
– – 1.19% 18
2025
Q1 		$1.26M Sell
1,530
-25
-2% -$20.8K 1.35% 14
2024
Q4 		$1.2M Sell
1,555
-175
-10% -$145K 1.22% 19
2024
Q3 		$1.53M Buy
1,730
+25
+1% +$22.5K 1.41% 14
2024
Q2 		$1.54M Buy
+1,705
New +$1.36M 1.53% 14
2023
Q4 		$1.03M Sell
1,775
-350
-16% -$204K 1.09% 18
2023
Q3 		$1.14M Hold
2,125
– – 1.3% 17
2023
Q2 		$997K Hold
2,125
– – 1.07% 19
2023
Q1 		$730K Hold
2,125
– – 0.76% 29
2022
Q4 		$768K Hold
2,125
– – 0.78% 28
2022
Q3 		$687K Hold
2,125
– – 0.82% 30
2022
Q2 		$701K Sell
2,125
-225
-10% -$67.5K 0.69% 32
2022
Q1 		$673K Sell
2,350
-56
-2% -$14.4K 0.59% 39
2021
Q4 		$665K Buy
+2,406
New +$610K 0.58% 47

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Alan B. Lancz & Associates's LLY Position: Q1 2026 in Review

Alan B. Lancz & Associates reduced its Eli Lilly (LLY) stake by 9.9% in Q1 2026, selling an estimated $157K and leaving 1,415 shares worth $1.3M. The position accounts for 1.26% of the portfolio, ranked #17.

Alan B. Lancz & Associates first reported a position in LLY in Q4 2021 and has held it in 17 quarters since. The position peaked at $1.69M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Alan B. Lancz & Associates held 1,415 shares of Eli Lilly worth $1.3M as of Q1 2026.
  • Alan B. Lancz & Associates sold 155 Eli Lilly shares in Q1 2026, an estimated $157K.
  • Eli Lilly made up 1.26% of Alan B. Lancz & Associates's portfolio in Q1 2026, its #17 holding.
  • Alan B. Lancz & Associates first reported a position in Eli Lilly in Q4 2021 and has held it in 17 quarters since.
  • Alan B. Lancz & Associates's Eli Lilly position peaked at $1.69M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Alan B. Lancz & Associates's 13F filing for Q1 2026, filed 5 May 2026.